155 related articles for article (PubMed ID: 2499104)
21. [Expression and prognostic indicators of type 1 and type 2 Lewis blood group antigens in colorectal cancers].
Asai S; Watanabe T; Sakamoto J; Kiriyama K; Ito K; Akiyama S; Takagi H
Nihon Geka Gakkai Zasshi; 1994 Oct; 95(10):753-62. PubMed ID: 7823897
[TBL] [Abstract][Full Text] [Related]
22. Expression of various sialylated carbohydrate antigens in malignant and nonmalignant pancreatic tissues.
Satomura Y; Sawabu N; Takemori Y; Ohta H; Watanabe H; Okai T; Watanabe K; Matsuno H; Konishi F
Pancreas; 1991 Jul; 6(4):448-58. PubMed ID: 1678888
[TBL] [Abstract][Full Text] [Related]
23. Comparative studies on the expression of tumor-associated glycoprotein (TAG-72), CA 19-9 and DU-PAN-2 in normal, benign and malignant pancreatic tissue.
Takasaki H; Tempero MA; Uchida E; Büchler M; Ness MJ; Burnett DA; Metzgar RS; Colcher D; Schlom J; Pour PM
Int J Cancer; 1988 Nov; 42(5):681-6. PubMed ID: 3053465
[TBL] [Abstract][Full Text] [Related]
24. MUC1 and MUC2 expression in pancreatic ductal carcinoma obtained by fine-needle aspiration.
Chhieng DC; Benson E; Eltoum I; Eloubeidi MA; Jhala N; Jhala D; Siegal GP; Grizzle WE; Manne U
Cancer; 2003 Dec; 99(6):365-71. PubMed ID: 14681945
[TBL] [Abstract][Full Text] [Related]
25. The distribution and localization of the monoclonal antibody-defined antigen 19-9 (CA19-9) in chronic pancreatitis and pancreatic carcinoma. An immunohistochemical study.
Makovitzky J
Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 51(6):535-44. PubMed ID: 2878526
[TBL] [Abstract][Full Text] [Related]
26. Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer.
Tempero MA; Uchida E; Takasaki H; Burnett DA; Steplewski Z; Pour PM
Cancer Res; 1987 Oct; 47(20):5501-3. PubMed ID: 3308077
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical staining of pancreatic cancer with CA19-9, KM01, unabsorbed CEA, and absorbed CEA. A comparison with normal pancreas and chronic pancreatitis.
Shimizu M; Saitoh Y; Ohyanagi H; Itoh H
Arch Pathol Lab Med; 1990 Feb; 114(2):195-200. PubMed ID: 1689141
[TBL] [Abstract][Full Text] [Related]
28. [Ca 19-9 antigen in differentiation of pancreatic inflammatory and neoplastic tumors].
Markocka-Maczka K
Wiad Lek; 2003; 56(11-12):537-40. PubMed ID: 15058160
[TBL] [Abstract][Full Text] [Related]
29. Fucosyltransferase-producing sialyl Le(a) and sialyl Le(x) carbohydrate antigen in benign and malignant gastrointestinal mucosa.
Dohi T; Hashiguchi M; Yamamoto S; Morita H; Oshima M
Cancer; 1994 Mar; 73(6):1552-61. PubMed ID: 7908856
[TBL] [Abstract][Full Text] [Related]
30. Expression and diagnostic evaluation of the human tumor-associated antigen RCAS1 in pancreatic cancer.
Akashi T; Oimomi H; Nishiyama K; Nakashima M; Arita Y; Sumii T; Kimura T; Ito T; Nawata H; Watanabe T
Pancreas; 2003 Jan; 26(1):49-55. PubMed ID: 12499917
[TBL] [Abstract][Full Text] [Related]
31. Histochemical localization and analysis of blood group-related antigens in human pancreas using immunostaining with monoclonal antibodies and exoglycosidase digestion.
Ito N; Nishi K; Nakajima M; Okamura Y; Hirota T
J Histochem Cytochem; 1990 Sep; 38(9):1331-40. PubMed ID: 2387986
[TBL] [Abstract][Full Text] [Related]
32. CA 50 compared with CA 19-9 as a serum tumour marker for pancreatic carcinoma.
Pasquali C; Sperti C; D'Andrea AA; Costantino V; Filipponi C; Pedrazzoli S
Ital J Gastroenterol; 1994 May; 26(4):169-73. PubMed ID: 7949259
[TBL] [Abstract][Full Text] [Related]
33. ABH and related histo-blood group antigens in normal & malignant human endometrium in relation to genetic and hormonal factors.
Skovlund VR
APMIS Suppl; 1997; 69():1-33. PubMed ID: 9254838
[TBL] [Abstract][Full Text] [Related]
34. Cancer-associated alterations of blood group antigen expression in the human pancreas.
Itzkowitz SH; Yuan M; Ferrell LD; Ratcliffe RM; Chung YS; Satake K; Umeyama K; Jones RT; Kim YS
J Natl Cancer Inst; 1987 Sep; 79(3):425-34. PubMed ID: 2442445
[TBL] [Abstract][Full Text] [Related]
35. Determination of CA 19-9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis.
Malesci A; Tommasini MA; Bonato C; Bocchia P; Bersani M; Zerbi A; Beretta E; Di Carlo V
Gastroenterology; 1987 Jan; 92(1):60-7. PubMed ID: 3465666
[TBL] [Abstract][Full Text] [Related]
36. Structural convergence of antibody binding of carbohydrate determinants in Lewis Y tumor antigens.
Ramsland PA; Farrugia W; Bradford TM; Mark Hogarth P; Scott AM
J Mol Biol; 2004 Jul; 340(4):809-18. PubMed ID: 15223322
[TBL] [Abstract][Full Text] [Related]
37. Differential MUC 1 expression in normal and neoplastic human pancreatic tissue. An immunohistochemical study of 60 samples.
Monges GM; Mathoulin-Portier MP; Acres RB; Houvenaeghel GF; Giovannini MF; Seitz JF; Bardou VJ; Payan MJ; Olive D
Am J Clin Pathol; 1999 Nov; 112(5):635-40. PubMed ID: 10549250
[TBL] [Abstract][Full Text] [Related]
38. Correlation of expression of H/Le(y)/Le(b) antigens with survival in patients with carcinoma of the lung.
Miyake M; Taki T; Hitomi S; Hakomori S
N Engl J Med; 1992 Jul; 327(1):14-8. PubMed ID: 1317941
[TBL] [Abstract][Full Text] [Related]
39. Immunoreactivity of Lewis blood group and mucin peptide core antigens: correlations with grade of dysplasia and malignant transformation in the colorectal adenoma-carcinoma sequence.
Baldus SE; Hanisch FG; Pütz C; Flucke U; Mönig SP; Schneider PM; Thiele J; Hölscher AH; Dienes HP
Histol Histopathol; 2002 Jan; 17(1):191-8. PubMed ID: 11813869
[TBL] [Abstract][Full Text] [Related]
40. Lewis Antigen Phenotype and Survival of Patients With Pancreatic Cancer.
Kwon S; Kim S; Giovannucci EL; Hidalgo M; Markey MK; Bovik AC; Kwon MJ; Kim KJ; Im H; Park JY; Bang S; Park SW; Song SY; Chung MJ
Pancreas; 2020; 49(10):1348-1354. PubMed ID: 33122524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]